SAN FRANCISCO, Feb. 24, 2020 /PRNewswire/ -- The global contrast
media market size is expected to reach
USD 6.9 billion by 2027, exhibiting a
CAGR of 3.6% during the forecast period, according to a new
report published by Grand View Research, Inc. Increasing burden of
chronic diseases is driving the demand for diagnostic imaging
procedures which are anticipated to fuel the contrast agents market
growth.
Key suggestions from the report:
- Iodinated contrast media was the largest segment in 2019 and
is anticipated to remain dominant over the forecast period as the
products have excellent radio-opacity and low toxicity
- X-ray/ CT was the largest modality segment in 2019, in terms
of revenue share, owing to wide acceptance and cost-efficiency of
the techniques
- Cardiovascular diseases is projected to witness the fastest
growth over the forecast period due to label extensions for
ultrasound and X-ray/ CT contrast agents in U.S. For instance, in
2016, the U.S. FDA approved Lumason for use in liver
ultrasonography
- North America dominated the
contrast media/contrast agents market with the largest revenue
share of 44.3% in 2019 owing to the presence of well-established
healthcare infrastructure and availability of advanced
technology
- Some of the key players operating in the market are Bayer
AG; General Electric Company; Guerbet; Lantheus Medical Imaging,
Inc.; Bracco Diagnostic, Inc.; Trivitron Healthcare; nano
Therapeutics Pvt. Ltd.; and iMAX
Read 102 page research report with ToC on "Contrast Media
Market Size, Share & Trends Analysis Report By Product Type
(Iodinated, Gadolinium-based), By Application (Neurological,
Cancer, CVDs), By Modality (MRI, X-ray/CT), And Segment Forecasts,
2020 - 2027" at:
https://www.grandviewresearch.com/industry-analysis/contrast-media-contrast-agents-market
The imaging tests such as Computed Tomography (CT), Magnetic
Resonance Imaging (MRI), and x-rays have become an inevitable part
of diagnosis for most of the diseases. The large-scale penetration
of imaging technology in healthcare has increased the demand for
contrast media. Newer contrast agents are constantly being
discovered and investigated. Also, the safety of contrast agents
for clinical use is under strict scrutiny.
The rapid rise in the use of medical imaging during the last few
decades has resulted in a substantial increase in the use of
radiologic contrast media. Half of the around 76.0 million computed
tomographic and 34.0 million magnetic resonance imaging
examinations performed annually include the use of intravenous
contrast agents.
Diagnostic imaging modalities are being increasingly used owing
to advancements in the underlying technology, ranging from
equipment to administration technology. Innovative products such as
syringeless injectors help achieve greater accuracy in delivering
the right dose of contrast agents as well as reduce wastage. These
injectors enable shorter examination time, leading to increased
patient throughput. In 2016, the first syringeless injector was
launched by Bracco Diagnostics in U.S.for multi-patient use to
increase the number of scans performed in a day.
Grand View Research has segmented the global contrast media
market based on product type, modality, application, and
region:
- Contrast Media Market Product Type Outlook (Revenue, USD
Million, 2016 - 2027)
-
- Iodinated
- Barium-based
- Gadolinium-based
- Microbubble
- Contrast Media Market Modality Outlook (Revenue, USD
Million, 2016 - 2027)
-
- Contrast Media Market Application Outlook (Revenue, USD
Million, 2016 - 2027)
-
- Cardiovascular Disorders
- Neurological Disorders
- Gastrointestinal Disorders
- Cancer
- Nephrological Disorders
- Musculoskeletal Disorders
- Others
- Contrast Media Market Regional Outlook (Revenue, USD
Million, 2016 - 2027)
-
- North America
-
- Europe
-
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Ukraine
- Netherlands
- Switzerland
- Sweden
- Asia Pacific
-
- Japan
- China
- India
- Australia
- South Korea
- Indonesia
- Malaysia
- Singapore
- Thailand
- Taiwan
- Latin America
-
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
-
- South Africa
- Saudi Arabia
- UAE
- Egypt
- Israel
Find more research reports on Medical Devices
Industry, by Grand View Research:
- Endoscopes Market – Global endoscopes market size was valued at
USD 10.4 billion in 2019 and is
estimated to register a CAGR of 8.8% over the forecast period.
- Viscosupplementation Market – Global viscosupplementation
market size was valued at around USD 3.8
billion in 2019 and is projected to expand at a CAGR of 9.2%
over the forecast period.
- Surgical Navigation Systems Market – Global surgical navigation
systems market size was valued at USD 833.48
million in 2019 and is expected to expand at a CAGR of 7.2%
over the forecast period.
Gain access to Grand View Compass, our BI enabled
intuitive market research database of 10,000+ reports
About Grand View Research
Grand View Research, U.S.-based market research and consulting
company, provides syndicated as well as customized research reports
and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425
analysts and consultants, adding more than 1200 market research
reports to its vast database each year. These reports offer
in-depth analysis on 46 industries across 25 major countries
worldwide. With the help of an interactive market intelligence
platform, Grand View Research helps Fortune 500 companies and
renowned academic institutes understand the global and regional
business environment and gauge the opportunities that lie
ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter
Logo:
https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg